Last reviewed · How we verify
Staphylococcal infectious disease — Treatment Landscape & Competitive Intelligence
5 marketed
0 Phase 3
0 Phase 2
Live · 30-min refresh
Marketed treatment landscape
| Drug | Generic | Sponsor | Class | Target | Line of therapy | First approval |
|---|---|---|---|---|---|---|
| Bactocill In Plastic Container | OXACILLIN | Apothecon | Dual 3',5'-cyclic-AMP and -GMP phosphodiesterase 11A, Prostaglandin G/H synthase 1, Prostaglandin G/H synthase 2 | 1971-01-01 | ||
| Nallpen In Plastic Container | NAFCILLIN SODIUM | Pfizer | Penicillin-class Antibacterial | 1965-01-01 | ||
| Nallpen In Plastic Container | NAFCILLIN | Pfizer | Penicillin-class Antibacterial | 1965-01-01 | ||
| Lincocin | LINCOMYCIN | Pfizer | lincomycin | 1964-01-01 | ||
| Vancocin | vancomycin | ANI Pharmaceuticals | Alpha-2A adrenergic receptor, D-alanyl-D-alanine dipeptidase, UDP-N-acetylglucosamine--N-acetylmuramyl-(pentapeptide) pyrophosphoryl-undecaprenol N-acetylglucosamine transferase |
Phase 3 pipeline
Phase 2 pipeline
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Sponsor landscape
- Pfizer · 3 drugs in Staphylococcal infectious disease
- · 1 drug in Staphylococcal infectious disease
- ANI Pharmaceuticals · 1 drug in Staphylococcal infectious disease
- Apothecon · 1 drug in Staphylococcal infectious disease
Subscribe to ongoing alerts
Every new regulatory action, PDUFA date, or trial completion in Staphylococcal infectious disease:
- Staphylococcal infectious disease treatment updates — RSS
- Staphylococcal infectious disease treatment updates — Atom
- Staphylococcal infectious disease treatment updates — JSON
Cite this brief
Drug Landscape (2026). Staphylococcal infectious disease — Treatment Landscape & Competitive Intelligence Brief. https://druglandscape.com/ci/disease/staphylococcal-infectious-disease. Accessed 2026-06-10.
Related
- Staphylococcal infectious disease full disease profile — treatment pathway, diagnostics, guidelines
- Browse all CI briefs
- Build a custom feed
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing